Abstract
The pathology of transmissible spongiform encephalopathies (TSEs) is strongly associated with the structural conversion of the cellular prion protein (PrPC) into a misfolded isoform (PrPSc) that assembles into amyloid fibrils. Since increased levels of oxidative stress have been linked to prion diseases, we investigated the metal-induced oxidation of human PrP (90-231). A novel in vitro conversion assay based on aerobic incubation of PrP in the presence of elemental copper pellets at pH 5 was established, resulting in aggregation of highly β-sheeted prion proteins. We show for the first time that two discrete oligomeric species of elongated shape, approx. 25 mers and 100 mers, are formed on the pathway of oxidative PrP aggregation in vitro, which are well characterized regarding shape and size using small-angle X-ray scattering (SAXS), dynamic light scattering (DLS), and electron microscopy (EM). Considering that small oligomers of highly similar size have recently been reported to show the highest specific infectivity within TSE-infected brain tissues of hamsters, the novel oligomers observed in this study are interesting candidates as agent causing neurodegenerative and/or self-propagating effects. Moreover, our results significantly strengthen the theory that oxidative stress might be an influence that leads to substantial structural conversions of PrP in vivo.
| Original language | English |
|---|---|
| Journal | Journal of Structural Biology |
| Volume | 157 |
| Issue number | 2 |
| Pages (from-to) | 308-320 |
| Number of pages | 13 |
| ISSN | 1047-8477 |
| DOIs | |
| Publication status | Published - 02.2007 |
Funding
We are grateful to Mirjam Koker for establishing the expression and purification of PrP and to Alexander Fast for excellent technical assistance. This work was supported by the Deutsche Luft- und Raumfahrtagentur (DLR, Projektträger Gesundheitsforschung) via grant 01KO0206 (to C.B.), the Deutsche Forschungsgemeinschaft via Grant 436 BUL/18/03/05 (to C.B.), by the DAAD via Grant 415-br-probal/ale-03/17635 (to C.B.), and the RiNA GmbH Berlin, Germany.
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)